New business launch for Irvine Pharmaceutical Services
Irvine Pharmaceutical Services, a US service provider for pharma, biotech and medical device companies, is to launch a new subsidiary in the New Year.
Irvine Pharmaceutical Services, a US service provider for pharma, biotech and medical device companies, is to launch a new subsidiary in the New Year.
The new division – Aviro Biopharmaceuticals – will provide formulation development and aseptic fill-and-finish services. The focus there will be on developing optimised production processes and providing dependable filling, lyophilisation and packaging capabilities for early phase clinical trial materials.
‘We are very excited about this extension of our company,’ said Assad J. Kazeminy, ceo and founder of Irvine Pharmaceutical Services. ‘Avrio will help round out our existing capabilities and its connection to Irvine will also make it possible to provide our clients with broader services via seamless partnership.’
Since early 2007, Irvine Pharmaceutical Services has experienced extensive growth and has made significant upgrades in its lab equipment and infrastructure. The latest extension to the company forms part of the company’s overall growth strategy to improve services and product offerings to clients.